The variation of T cell receptor (TCR) diversity and genomic human leukocyte antigen-I (HLA-I) among non-small cell lung cancer (NSCLC) patients expressing high PDL1 versus those with low or no PDL1

A. Abed; A. Beasley; C. Leslie; A. Reid; M. Millward; E. S. Gray

doi:10.1016/j.annonc.2022.07.1808

The variation of T cell receptor (TCR) diversity and genomic human leukocyte antigen-I (HLA-I) among non-small cell lung cancer (NSCLC) patients expressing high PDL1 versus those with low or no PDL1

A. Abed, A. Beasley, C. Leslie, A. Reid, M. Millward, E. S. Gray

Internal Medicine

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S1327-S1328
Number of pages	2
Journal	Annals of Oncology
Volume	33
Issue number	7
DOIs	https://doi.org/10.1016/j.annonc.2022.07.1808
Publication status	Published - Sept 2022
Event	2022 Annual Meeting of the European-Society-for-Medical-Oncology - , France Duration: 9 Sept 2022 → 13 Sept 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.annonc.2022.07.1808

Cite this

@article{eb27819495794f6c99d678f5fc1cfcb6,

title = "The variation of T cell receptor (TCR) diversity and genomic human leukocyte antigen-I (HLA-I) among non-small cell lung cancer (NSCLC) patients expressing high PDL1 versus those with low or no PDL1",

author = "A. Abed and A. Beasley and C. Leslie and A. Reid and M. Millward and Gray, {E. S.}",

year = "2022",

month = sep,

doi = "10.1016/j.annonc.2022.07.1808",

language = "English",

volume = "33",

pages = "S1327--S1328",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "7",

note = "2022 Annual Meeting of the European-Society-for-Medical-Oncology, ESMO 2022 ; Conference date: 09-09-2022 Through 13-09-2022",

}

Abed, A, Beasley, A, Leslie, C, Reid, A, Millward, M & Gray, ES 2022, 'The variation of T cell receptor (TCR) diversity and genomic human leukocyte antigen-I (HLA-I) among non-small cell lung cancer (NSCLC) patients expressing high PDL1 versus those with low or no PDL1', Annals of Oncology, vol. 33, no. 7, pp. S1327-S1328. https://doi.org/10.1016/j.annonc.2022.07.1808

The variation of T cell receptor (TCR) diversity and genomic human leukocyte antigen-I (HLA-I) among non-small cell lung cancer (NSCLC) patients expressing high PDL1 versus those with low or no PDL1. / Abed, A.; Beasley, A.; Leslie, C. et al.
In: Annals of Oncology, Vol. 33, No. 7, 09.2022, p. S1327-S1328.

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

TY - JOUR

T1 - The variation of T cell receptor (TCR) diversity and genomic human leukocyte antigen-I (HLA-I) among non-small cell lung cancer (NSCLC) patients expressing high PDL1 versus those with low or no PDL1

AU - Abed, A.

AU - Beasley, A.

AU - Leslie, C.

AU - Reid, A.

AU - Millward, M.

AU - Gray, E. S.

PY - 2022/9

Y1 - 2022/9

U2 - 10.1016/j.annonc.2022.07.1808

DO - 10.1016/j.annonc.2022.07.1808

M3 - Abstract/Meeting Abstract

SN - 0923-7534

VL - 33

SP - S1327-S1328

JO - Annals of Oncology

JF - Annals of Oncology

IS - 7

T2 - 2022 Annual Meeting of the European-Society-for-Medical-Oncology

Y2 - 9 September 2022 through 13 September 2022

ER -